Tom Neary has been appointed chief financial officer of SEngine Precision Medicine. Neary most recently worked as CFO at Space Venture Partners, and prior to that as the top financial executive for Spaceflight Industries. His experience also includes positions at Microsoft (NASDAQ: [[ticker:MSFT]]). Seattle-based SEngine has commercialized a diagnostic test used to match a patient to the most appropriate cancer treatments. The company is also developing a pipeline of cancer drugs.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
